Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06080646

Reward Processing and Depressive Subtypes: Identifying Neural Biotypes

Deficits in motivation and pleasure are common in depression, and thought to be caused by alterations in the ways in which the brain anticipates, evaluates, and adaptively uses reward-related information. However, reward processing is a complex, multi-circuit phenomenon, and the precise neural mechanisms that contribute to the absence or reduction of pleasure and motivation are not well understood. Variation in the clinical presentation of depression has long been a rule rather than an exception, including individual variation in symptoms, severity, and treatment response. This heterogeneity complicates understanding of depression and thwarts progress toward disease classification and treatment planning. Discovery of depression-specific biomarkers that account for neurobiological variation that presumably underlies distinct clinical manifestations is critical to this larger effort.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

San Francisco Healthcare System

San Francisco, California, 94121, United States

Location status: Recruiting

Location contact

Jason Hemmerle, MBA

CONTACT

[email protected]

415-221-4810 ext. 24711

About this study

This study combines clinically motivated questions with in-depth study of neurobiological mechanisms to evaluate how reward system neurobiology contributes to expression of reward-related deficits, such as decreased pleasure and motivation in major depressive disorder (MDD). Conceptually, the investigator will use a multi-measure approach, by studying basic brain responses to reward anticipation as well as higher-order aspects of reward processing necessary for decision-making.

Methodologically, the investigator will combine fMRI, EEG, and behavioral assessment, to more fully characterize reward-related brain functions and their clinical correlates. In addition to evaluating reward effects between MDD and healthy controls (HC), the investigator will also focus on understanding the relationship between reward processing and clinical features of high relevance to depression, with an emphasis on suicidality.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

  • Our studies require some in-person visits to our research lab, located at 42nd Ave and Clement St in San Francisco.
  • Because this study includes an MRI, part of the screening process will be to ensure you don't have any metal in your body, you do not have head or neck tattoos, and you are comfortable inside the MRI scanner.

Inclusion criteria

  • 18-70 years with a diagnosis of major depressive disorder (MDD) for MDD group, or without for unaffected comparison (UC) group
  • Negative metal screen for MRI safety
  • Normal (or corrected to normal) vision

Exclusion criteria

  • Past or present neurological problems (including seizures and head trauma resulting in neurological or cognitive symptoms)
  • Loss of consciousness (LOC) greater than 30 minutes or any LOC with neurologic symptoms
  • Major medical conditions (e.g., seizure disorders, treatment with anticonvulsant medication, endocrine disorders, significant cardiac pathology)
  • Substance dependence, within the past year, or failed urine toxicology on the day of neuroimaging sessions
  • Known claustrophobia
  • Current Pregnancy
  • IQ estimate < 70

Treatment and study plan

cross-sectional MRI and EEG assessments (NO INTERVENTION)

Other

n/a there is no intervention in this observational study

Other names: cross-sectional MRI and EEG assessments

Primary outcomes

  1. Stimulus preceding negativity

    Time frame: 1 month (EEG measure of reward anticipation)

    Stimulus preceding negativity (EEG measure of reward anticipation) of reward-related brain activation patterns and EEG responses on participants

  2. Reward positivity

    Time frame: 1 month (EEG measure of reward feedback)

    Reward positivity (EEG measure of reward feedback) of reward-related brain activation patterns and EEG responses on participants

  3. Late positive potential

    Time frame: 1 month (EEG measure of effective salience)

    Late positive potential (EEG measure of affective salience) of reward-related brain activation patterns and EEG responses on participants

  4. fMRI response to win vs. loss reward feedback

    Time frame: 1 month (fMRI data)

    fMRI response to win vs. loss reward feedback of reward-related brain activation patterns and EEG responses on participants

Study contacts

Contact information is provided by the study sponsor or research team.

Jason Hemmerle, MBA

CONTACT

[email protected]

415 221 4810 ext. 24711

Kaitlyn Dal Bon, BA

CONTACT

[email protected]

415 221 4810 ext. 23946

Sponsors and collaborators

Lead sponsor

San Francisco Veterans Affairs Medical Center

Fed

Registry information

Official study title

Reward Processing and Depressive Subtypes: Identifying Neural Biotypes Related to Suicide Risk, Resilience, and Treatment Response

Important dates

Study start
2021
Primary completion
2025
Study completion
2025
First posted
Oct 12, 2023
Registry last updated
Aug 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.